Scientific Program

  1. Home
  2. Scientific Program

Scientific Program

Day 01 full schedule

Friday, 16th September 2022

Inaugration and Welcome Address

LUNCH

 
14:05-15:40| Session 1: Oncogenesis and Diagnosis Invited faculty: Dr Vivek Raj, Dr Anjali K Gupta, Dr Sandeep Vohra, Dr Ajitabh Srivastava, Dr Abhishek Agarwal

Oncogenesis in chronic liver diseases (HBV, HCV, PSC, NASH)Dr. S K Acharya

Screening and Surveillance for Malignancies in Chronic liver diseaseDr. P. Kar

SOL in liver: radiologic algorithmDr. Ruchi Rastogi

Biopsy or not to Biopsy in primary liver malignancyDr. Manav Wadhawan

Tea Break

 
16:10-17:40 | Session 2: Oncogenesis and Diagnosis Invited faculty: Dr Kaushal Madan, Dr Shefali Sardana, Dr Giriraj Bora, Dr Arun V, Dr Sandeep Batra

Debate : LTx for Hilar CCA Against - Dr Vivek Vij /For- Dr. Bala Chandran

Panel Discussion : Liver transplant for neuroendocrine tumours ModeratorPanel Members : Dr. S Sreejith, Dr. Vachan Hukkeri, Dr. Shabeer Ali, Dr. Selva Kumar, Dr. M. Srinivas Reddy

Day 02 full schedule

Saturday, 17th September 2022

Welcome Address

 
09:45-11:20 | Session 3 - Staging and ManagementInvited Faculty : Dr Ruchi Rastogi, Dr Vikram Kumar, Dr Abhideep Chaudhary, Dr Kauser Makhija, Dr K J Singh, Dr. Vasudevan

Staging systems for HCC Dr. Sanjiv Saigal

Staging of Hepatoblastoma impact and outcomeDr. Neerav Goyal

Dominant stricture in PSC - how to proceed?Dr. Ravichand Sidachari

CCA masqueradesDr. Biju Pottakat

Tea Break

 
11:50-14:00 | Session 4: Downstaging protocolsInvited Faculty : Dr Shahnawaz B Kaloo, Dr Priyanka Singh, Dr Kshetij Sisodia, Dr Hitendra Garg, Dr Sanjay Sharma, Dr Rashi Agarwal

Downstaging for HCC within UCSF and Milan criteria - does it make a difference? Dr. Sunil Taneja

Role of Interventional Radiology - TACE versus TARE as a downstaging modality Dr. Shahnawaz B Kaloo

Role of SBRT in downstagingDr Jas Karan

Liver resection as a downstaging protocolDr.Giriraj Bora

Code of Medical Ethics Dr. Girish Tyagi/ Dr. Arun K Gupta

Code of Medical Ethics Dr. Girish Tyagi/ Dr. Arun K Gupta

LUNCH

 
14:35-16:30 | Session 5 : Management of HCC with CirrhosisInvited Faculty : Dr Sanjiv Saigal, Dr. Shyam Sunder Mahansaria, Dr Vivek Saxena, Dr Nikhil Agarwal, Dr Abhishek Deo, Dr Sanjay, Dr Yuktansh Pandey

Preoperative biliary decompression Dr. Vikas Singla

Assessment and Augmenting remnant liver volumeDr. Mohd. Nayeem

Liver Resection in CirrhosisDr. Rajesh Dey

Debate: Liver transplant for advanced HCC (with PVTT)For-Dr. Prashant Bhangui, Against- Dr Naimish Mehta

 
16:40-17:50 | Session 6 : Recurrence PreventionInvited Faculty : Dr Arun K ML, Dr Jaspriya Bal, Dr. Mohammed Abdun Nayeem, Dr Bhuvan Chugh, Dr Vikas Goswami

Intraoperative measuresDr. Ramdip Ray

Tailoring immunosuppressionDr. Kaushal Madan

Surveillance protocol for HCC recurrence post LTDr. A.C. Anand

Day 03 full schedule

Sunday, 18th September 2022

Welcome Address

 
09:45-11:20 | Session 7 : Liver transplant for metastatic disease Invited faculty: Dr Shaleen Agarwal, Dr Sudeep Khanna, Dr. S Sreejith, Dr Priyaranjan, Dr Sumesh Kaistha, Dr Vivek Mangla

Debate : Liver transplant for colorectal metastases?Against - Dr. Sonal Asthana / For- Dr. Sujoy Pal

Liver transplant for non-colorectal non-neuroendocrine liver mets Dr. Gaurav Chaubal

Newer techniques for metastatic disease: ALPS/Rapid/APOLTDr. Shivendra Singh

Sponsored talk by Dr Amit Rastogi : "Role of mTOR inhibitors in HCC recurrence"

 
11:50-13:00 | Session 8 : Miscellaneous Invited faculty: Dr Vikram Kumar, Dr. Raman Girn, Dr Vidyut Bhatia, Dr Nivedita Pandey

Is ABOi LT indicated for malignancy?Dr. V Pamecha

HCC in pediatric patientsDr. Ramandeep Singh Arora

Liver transplant after treated malignancyDr. Amit Rastogi

LUNCH

 
14:10-15:45 | Session 9: MiscellaneousInvited faculty: Dr Amir Mushtaq Parray, Dr P. K.Mishra, Dr Rajesh Dey, Dr Shekhar S Jadaun

PTLD after Liver transplant Dr. P.K. Das

Surveillance, Diagnosis and management of malignancies post liver transplant Dr. Nitesh Rohtagi

Managing HCC with bile duct tumor thrombus Dr. Ravi Mohanka

Immunotherapy in metastatic HCCDr. Bhuvan Chugh

Vote of thanks